Mesenchymal stem cells ... that drive hepatic fibrosis. These immunomodulatory, antifibrotic, and liver specific features make HepaStem cells well-suited to the treatment of hepatic diseases ...

HepaStem is a highly advanced cell therapy platform consisting of human liver-derived stem cells that are ethically ... thereby reducing fibrosis (Fig. 1). This combination of immunomodulatory ...

Several anatomical and immunological barriers must be overcome before successful gene therapy can become a reality for cystic fibrosis (CF) patients. An approach considering stem cell-based ...

The ECM components in fibrotic liver are similar regardless of the underlying cause. Activation of hepatic stellate cells is the ... of diagnosis and treatment of hepatic fibrosis.

These conditions damage liver cells (hepatocytes ... points for potential liver fibrosis therapies. The authors have proposed several ideas for how such a therapy could be implemented, which ...